These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 26188539
1. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS). Ota T, Ishii H, Suzuki S, Shibata Y, Tatami Y, Harata S, Shimbo Y, Takayama Y, Tanaka A, Kawamura Y, Osugi N, Maeda K, Kondo T, Murohara T. Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539 [Abstract] [Full Text] [Related]
4. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study. Wongcharoen W, Sutthiwutthichai S, Gunaparn S, Phrommintikul A. BMC Cardiovasc Disord; 2017 Jan 05; 17(1):10. PubMed ID: 28056802 [Abstract] [Full Text] [Related]
8. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl. Piao ZH, Jin L, Kim JH, Ahn Y, Kim YJ, Cho MC, Kim CJ, Kim HS, Liu B, Jeong MH, Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Am J Cardiol; 2017 Jul 15; 120(2):174-180. PubMed ID: 28532771 [Abstract] [Full Text] [Related]
9. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. Lee KH, Jeong MH, Kim HM, Ahn Y, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Rha SW, Bae JH, Cho JG, Park SJ, KAMIR (Korea Acute Myocardial Infarction Registry) Investigators. J Am Coll Cardiol; 2011 Oct 11; 58(16):1664-71. PubMed ID: 21982310 [Abstract] [Full Text] [Related]
10. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events. Puri R, Nissen SE, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nicholls SJ. Eur J Prev Cardiol; 2016 Mar 11; 23(5):474-85. PubMed ID: 25691546 [Abstract] [Full Text] [Related]
12. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl. Spencer FA, Goldberg RJ, Gore JM, Fox KA, Avezum A, Agnelli G, Kritharides L, Anderson FA, Goodman SG, FitzGerald G, Allegrone J, Brieger D, GRACE Investigators. Am J Cardiol; 2007 Sep 15; 100(6):913-8. PubMed ID: 17826369 [Abstract] [Full Text] [Related]
13. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol. Ogita M, Miyauchi K, Miyazaki T, Naito R, Konishi H, Tsuboi S, Dohi T, Kasai T, Yokoyama T, Okazaki S, Kurata T, Daida H. Heart Vessels; 2014 Jan 15; 29(1):35-41. PubMed ID: 23516028 [Abstract] [Full Text] [Related]
14. Projected Real-World Effectiveness of Using Aggressive Low-Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada. Alter DA, Tu JV, Koh M, Jackevicius CA, Austin PC, Rezai MR, Bhatia RS, Johnston S, Udell JA, Ko DT. J Am Heart Assoc; 2018 May 12; 7(10):. PubMed ID: 29754125 [Abstract] [Full Text] [Related]
15. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients. Munkhaugen J, Sverre E, Otterstad JE, Peersen K, Gjertsen E, Perk J, Gullestad L, Moum T, Dammen T, Husebye E. Eur J Prev Cardiol; 2017 Jun 12; 24(9):981-989. PubMed ID: 28196429 [Abstract] [Full Text] [Related]
17. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program). Nagashima M, Koyanagi R, Kasanuki H, Hagiwara N, Yamaguchi J, Atsuchi N, Honda T, Haze K, Sumiyoshi T, Urashima M, Ogawa H, Heart Institute of Japan, Department of Cardiology (HIJC) Investigators. Am J Cardiol; 2007 Jun 01; 99(11):1523-8. PubMed ID: 17531574 [Abstract] [Full Text] [Related]